Carolina Biooncology Institute — Huntersville, North Carolina

Public research footprint of Carolina Biooncology Institute, compiled from the ClinicalTrials.gov public registry.

108

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced Solid Tumor · Advanced Solid Tumors · Non-Small Cell Lung Cancer · PDAC - Pancreatic Ductal Adenocarcinoma

Recently updated registry entries

NCT07573215 — Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic… (Available)
NCT05267626 — Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in… (Recruiting)
NCT03768063 — A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Carolina Biooncology Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.